Study of Miebo® for Dry Eye
This study is looking at how well two devices, the TearScience™ LipiView™ II and the Keratograph® 5M, can measure changes in your tear film after using Miebo®, a treatment for dry eye. Researchers will compare your tear film measurements before and after you use Miebo® at different times. The main goal is to see how Miebo® affects the thickness of the lipid (oily) layer of your tears, as measured by the LipiView™ II, one hour after you take the medication. You may be able to join if you are at least 18 years old and have a normal tear film. The study plans to enroll 20 participants, but its current status is unclear.
- Study design
- This is an open-label study, meaning both you and the researchers will know what treatment you are receiving. It plans to enroll 20 participants.
- What's involved
- Researchers will take various tear film measurements before you use Miebo® and at multiple times after you use it. You cannot use any eye drops, including over-the-counter lubricants, within 24 hours of your study visit.
- Compensation
- Not stated in the trial record.
- Follow-up
- The primary endpoint is measured at 1 hour after dosing Miebo®.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
A Single Center, Open-Label Study to Evaluate the Ability of the TearScience™ LipiView™ II Ocular Surface Interferometer and the Keratograph® 5M to Detect Tear Film Stability Utilizing Miebo®
At a glance
Conditions
Where it's being run
1 sites across 1 statesWho to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
What this trial measures
- Assess the effect of Miebo® on the TearScience™ LipiView™ II Ocular Surface Interferometer Lipid Layer Thickness (LLT) Evaluation1 hour
Number of subjects with an increase from baseline in lipid layer thickness as assessed by the TearScience™ LipiView™ II Ocular Surface Interferometer